Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells

被引:41
作者
Kao, I-Ting [1 ]
Yao, Chao-Ling [1 ]
Kong, Zwe-Ling [2 ]
Wu, Mei-Ling [1 ]
Chuang, Tzu-Lin [1 ]
Hwang, Shiaw-Min [1 ]
机构
[1] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu 30062, Taiwan
[2] Natl Taiwan Ocean Univ, Dept Food Sci, Cellular Immunol Lab, Chilung, Taiwan
关键词
D O I
10.1089/scd.2007.0033
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34(+) hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34(+) cells from UCB. In this study, the serum-free, expanded CD34(+) cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-gamma secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34(+) cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34(+) cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34(+) cells. NK cells induced from serum-free, expanded CD34(+) cells showed a higher concentration of IFN-gamma secretion and ability of cytotoxicity than those from freshly isolated CD34(+) cells. Therefore, ex vivo-expanded CD34(+) cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.
引用
收藏
页码:1043 / 1051
页数:9
相关论文
共 33 条
  • [1] Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO
  • [2] 2-7
  • [3] Carson William, 1996, Methods (Orlando), V9, P327, DOI 10.1006/meth.1996.0038
  • [4] Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency XI bone marrow cells
    CavazzanaCalvo, M
    HaceinBey, S
    Basile, GD
    DeCoene, C
    Selz, F
    LeDeist, F
    Fischer, A
    [J]. BLOOD, 1996, 88 (10) : 3901 - 3909
  • [5] What does it take to make a natural killer?
    Colucci, F
    Caligiuri, MA
    Di Santo, JP
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) : 413 - 425
  • [6] The biology of human natural killer-cell subsets
    Cooper, MA
    Fehniger, TA
    Caligiuri, MA
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (11) : 633 - 640
  • [7] Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
    Farag, SS
    Fehniger, TA
    Ruggeri, L
    Velardi, A
    Caligiuri, MA
    [J]. BLOOD, 2002, 100 (06) : 1935 - 1947
  • [8] Interleukin 15: biology and relevance to human disease
    Fehniger, TA
    Caligiuri, MA
    [J]. BLOOD, 2001, 97 (01) : 14 - 32
  • [9] Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures
    Giarratana, MC
    Vergé, V
    Schmitt, C
    Bertho, JM
    Kobari, L
    Barret, C
    Douay, L
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) : 46 - 54
  • [10] Current status of umbilical cord blood hematopoietic stem cell transplantation
    Gluckman, E
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (11) : 1197 - 1205